Unknown

Dataset Information

0

Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.


ABSTRACT: The CDKN2A gene located on chromosome region 9p21 encodes the cyclin-dependent kinase-4 inhibitor p16/INK4A, a negative cell cycle regulator. We analyzed p16/INK4A expression in different types of non-Hodgkin's lymphoma to determine whether the absence of this protein is involved in lymphomagenesis, while also trying to characterize the genetic events underlying this p16/INK4A loss. To this end, we investigated the levels of p16/INK4A protein using immunohistochemical techniques in 153 cases of non-Hodgkin's lymphoma, using as reference the levels found in reactive lymphoid tissue. The existence of gene mutation, CpG island methylation, and allelic loss were investigated in a subset of 26 cases, using single-strand conformational polymorphism and direct sequencing, Southern Blot, polymerase chain reaction, and microsatellite analysis, respectively. Loss of p16/INK4A expression was detected in 41 of the 112 non-Hodgkin's lymphomas studied (37%), all of which corresponded to high-grade tumors. This loss of p16/INK4A was found more frequently in cases showing tumor progression from mucosa-associated lymphoid tissue low-grade lymphomas (31 of 37) or follicular lymphomas (4 of 4) into diffuse large B-cell lymphomas. Analysis of the status of the p16/INK4A gene showed different genetic alterations (methylation of the 5'-CpG island of the p16/INK4A gene, 6 of 23 cases; allelic loss at 9p21, 3 of 16 cases; and nonsense mutation, 1 of 26 cases). In all cases, these events were associated with loss of the p16/INK4A protein. No case that preserved protein expression contained any genetic change. Our results demonstrate that p16/INK4A loss of expression contributes to tumor progression in lymphomas. The most frequent genetic alterations found were 5'-CpG island methylation and allelic loss.

SUBMITTER: Villuendas R 

PROVIDER: S-EPMC1853011 | biostudies-literature | 1998 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.

Villuendas R R   Sánchez-Beato M M   Martínez J C JC   Saez A I AI   Martinez-Delgado B B   García J F JF   Mateo M S MS   Sanchez-Verde L L   Benítez J J   Martínez P P   Piris M A MA  

The American journal of pathology 19980901 3


The CDKN2A gene located on chromosome region 9p21 encodes the cyclin-dependent kinase-4 inhibitor p16/INK4A, a negative cell cycle regulator. We analyzed p16/INK4A expression in different types of non-Hodgkin's lymphoma to determine whether the absence of this protein is involved in lymphomagenesis, while also trying to characterize the genetic events underlying this p16/INK4A loss. To this end, we investigated the levels of p16/INK4A protein using immunohistochemical techniques in 153 cases of  ...[more]

Similar Datasets

| S-EPMC3007178 | biostudies-literature
| S-EPMC2213160 | biostudies-literature
| S-EPMC1876918 | biostudies-literature
| S-EPMC3003740 | biostudies-literature
| S-EPMC4570141 | biostudies-literature
| S-EPMC3382785 | biostudies-other
| S-EPMC2723750 | biostudies-literature
| S-EPMC8462994 | biostudies-literature
| S-EPMC3679618 | biostudies-literature
| S-EPMC3127263 | biostudies-literature